Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 4
2003 2
2004 1
2005 2
2006 3
2007 5
2008 9
2009 7
2010 7
2011 1
2012 4
2013 6
2014 12
2015 6
2016 3
2017 10
2018 17
2019 19
2020 21
2021 15
2022 16
2023 14
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

162 results

Results by year

Filters applied: . Clear all
Page 1
Randomized trials of estrogen-alone and breast cancer incidence: a meta-analysis.
Chlebowski RT, Aragaki AK, Pan K, Mortimer JE, Johnson KC, Wactawski-Wende J, LeBoff MS, Lavasani S, Lane D, Nelson RA, Manson JE. Chlebowski RT, et al. Among authors: mortimer je. Breast Cancer Res Treat. 2024 Apr 23. doi: 10.1007/s10549-024-07307-9. Online ahead of print. Breast Cancer Res Treat. 2024. PMID: 38653905
Outcome prioritization and preferences among older adults with cancer starting chemotherapy in a randomized clinical trial.
Soto-Perez-de-Celis E, Dale W, Katheria V, Kim H, Fakih M, Chung VM, Lim D, Mortimer J, Cabrera Chien L, Charles K, Roberts E, Vazquez J, Moreno J, Lee T, Fernandes Dos Santos Hughes S, Sedrak MS, Sun CL, Li D. Soto-Perez-de-Celis E, et al. Among authors: mortimer j. Cancer. 2024 Apr 17. doi: 10.1002/cncr.35333. Online ahead of print. Cancer. 2024. PMID: 38630903
A phase I study of Mirvetuximab Soravtansine and gemcitabine in patients with FRα-positive recurrent ovarian, primary peritoneal, fallopian tube, or endometrial cancer, or triple negative breast cancer.
Cristea MC, Stewart D, Synold T, Ruel N, Mortimer J, Wang E, Jung A, Wilczynski S, Konecny GE, Eng M, Kilpatrick L, Han E, Dellinger T, Hakim A, Lee S, Morgan RJ, Wakabayashi MT, Frankel PH. Cristea MC, et al. Among authors: mortimer j. Gynecol Oncol. 2024 Mar;182:124-131. doi: 10.1016/j.ygyno.2023.12.017. Epub 2024 Jan 22. Gynecol Oncol. 2024. PMID: 38262235 Clinical Trial.
Pilot study of HER2 targeted 64 Cu-DOTA-tagged PET imaging in gastric cancer patients.
Hernandez MC, Yazaki P, Mortimer JE, Yamauchi D, Poku E, Park J, Frankel P, Kim J, Colcher DM, Wong J, Fong Y, Shively J, Woo Y. Hernandez MC, et al. Among authors: mortimer je. Nucl Med Commun. 2023 Dec 1;44(12):1151-1155. doi: 10.1097/MNM.0000000000001761. Epub 2023 Oct 30. Nucl Med Commun. 2023. PMID: 37901917
Inflammation-related proteins as biomarkers of treatment-related behavioral symptoms: A longitudinal study of breast cancer patients and age-matched controls.
Patel SK, Breen EC, Paz IB, Kruper L, Mortimer J, Wong FL, Bhatia S, Irwin MR, Behrendt CE. Patel SK, et al. Among authors: mortimer j. Brain Behav Immun Health. 2023 Jul 31;32:100670. doi: 10.1016/j.bbih.2023.100670. eCollection 2023 Oct. Brain Behav Immun Health. 2023. PMID: 37637432 Free PMC article.
162 results